Obesity is quickly becoming a worldwide epidemic, and there are currently no effective therapies. Despite their promise, early treatment strategies failed to demonstrate clinical efficacy, which has prompted researchers to focus on the development of combinatorial therapies. Some of the earlier strategies relied on stimulation of β3-adrenergic receptors, and there is recent evidence that the effect of β3-adrenergic activation could be potentiated by combining it with PPARβ-receptor activation. To explore this possibility in vivo, Fernando Rodríguez de Fonseca and colleagues subjected rats to co-treatment with a β3-adrenergic agonist and a PPARβ-activating ligand. This had an effect on multiple processes involved in energy balance, including feeding, thermogenesis and fatty acid oxidation, promoting an overall increase in energy expenditure and decrease in energy intake. These results suggest that pharmacological combination of PPARβ and β3-adrenergic receptor agonists could represent a promising therapy for treating obesity. Page 129
A combinatorial therapy for treating obesity
A combinatorial therapy for treating obesity. Dis Model Mech 1 January 2014; 7 (1): 1. doi:
Download citation file:
Advertisement
Cited by
DMM Journal Meeting 2023: Infectious Diseases Through an Evolutionary Lens

The abstract submission deadline for our 2023 Journal Meeting ‘Infectious Diseases Through an Evolutionary Lens’ is 14 July 2023. Find out more and register here.
The Forest of Biologists

The Forest of Biologists is a biodiversity initiative created by The Company of Biologists, with support from the Woodland Trust. For every Research and Review article published in Disease Models & Mechanisms a native tree is planted in a UK forest. In addition to this we are protecting and restoring ancient woodland and are dedicating these trees to our peer reviewers. Visit our virtual forest to learn more.
Propose a new Workshop for 2025

Do you have an idea for a Workshop? If so, click here. We are now accepting proposals for our 2025 Workshops programme. As the scientific organiser, your involvement will be focused on the science. We'll take care of all the logistics. In 2025 we'll continue our efforts to diversify our Workshop programme and will be reserving one of our Workshops for an application from a Global South country to host an event overseas.
How stromal cells restrict liver cancer invasion

In our recent editor’s choice, Liqin Zhu and colleagues describe how they used in vitro liver spheroid models consisting of both parenchymal and non-parenchymal cells to reveal a hepatoprotective role for peritumoral hepatic stellate cells in liver tumorigenesis.
And from perspective… Hacking haematopoiesis – emerging tools for examining variant effects

Thousands of genomic loci have been linked to hematopoietic traits and diseases, yet many await functional validation. Michael Gundry and Vijay G. Sankaran discuss recent advances in genome editing and the challenges associated with using these techniques to assess variant function in primary hematopoietic cells. a celebration of the achievements of female scientists, and a call to action for a culture shift in science.
Other journals from
The Company of Biologists